Catherine A. Sarkisian, MD, MSHS

Articles by Catherine A. Sarkisian, MD, MSHS

Proactive Care Management of AI-Identified At-Risk Patients Decreases Preventable Admissions

ByAnn C. Raldow, MD, MPH,Naveen Raja, DO, MBA,Chad W. Villaflores, MS,Samuel A. Skootsky, MD,Elizabeth A. Jaureguy, MSN, FNP-C,Hanina L. Rosenstein, MS,Sarah D. Meshkat, MHA,Sitaram S. Vangala, MS,Catherine A. Sarkisian, MD, MSHS

November 6th 2024

Proactive care management for artificial intelligence (AI)–identified at-risk patients reduced potentially preventable hospital admissions.

Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net

ByRichard K. Leuchter, MD,Catherine A. Sarkisian, MD, MSHS,Rebecca Trotzky-Sirr, MD,Eric K. Wei, MD, MBA,Carmen A. Carrillo, MA, MHS,Sitaram S. Vangala, MS,Charles Coffey Jr, MD, MS,Brad Spellberg, MD,Oleg Melamed, MD,Arthur C. Jeng, MD,John N. Mafi, MD, MPH

June 12th 2023

This study evaluates the impact of Choosing Wisely–based interventions on antibiotic prescribing for viral respiratory tract infections in a real-world safety-net setting.

Latest Updated Articles

Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net
Published: June 12th 2023 | Updated:
Proactive Care Management of AI-Identified At-Risk Patients Decreases Preventable Admissions
Published: November 6th 2024 | Updated:

Catherine A. Sarkisian, MD, MSHS

Articles by Catherine A. Sarkisian, MD, MSHS

Proactive Care Management of AI-Identified At-Risk Patients Decreases Preventable Admissions

Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net

Latest Updated Articles

Trending on AJMC

IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?

FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma

FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause

Revumenib Granted FDA Approval for R/R NPM1-Mutated AML

Eliminating Cost Sharing Boosted Follow-Up Colonoscopy Rates